⌘K
Loading ticker…
As of 2026-08-24, Rapport Therapeutics, Inc. Common Stock (RAPP) has a 3-month relative strength percentile of 88 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 76. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.9%, relative volume 1.32×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
RAPP is in a stage 2 uptrend, week 10. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 16.5% / 46.3%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
RAPP is held by 20 ETFs as of May 2026. Top owner: VTWO at 0.03% weight, $6M notional. Top 3 carry $15M.
Held by 43 ETFs · $116M across latest filings · largest weight 1.37% (XPH).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.03% | $6M | — |
| SCHASchwab U.S. Small-Cap ETF | 0.02% | $5M | — |
| VHTVanguard Health Care ETF | 0.02% | $3M | — |
| VFMO | 0.14% | $3M | +0.03 pp |
| AVSC | 0.08% | $2M | +0.02 pp |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 1.20% |
| $2M |
| +0.31 pp |
| VTWV | 0.07% | $910K | +0.02 pp |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $806K | — |
| ONEQ | 0.01% | $625K | — |
| IBBQ | 0.15% | $102K | +0.05 pp |
Showing 10 of 20 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RAPP Jan avg: -9.90% median: -9.90% win: 0% σ: 3.39% n: 2 2024-06-10 → 2026-07-31 | RAPP Feb avg: -14.89% median: -14.89% win: 50% σ: 33.92% n: 2 2024-06-10 → 2026-07-31 | RAPP Mar avg: 3.89% median: 3.89% win: 50% σ: 5.50% n: 2 2024-06-10 → 2026-07-31 | RAPP Apr avg: 10.02% median: 10.02% win: 100% σ: 5.85% n: 2 2024-06-10 → 2026-07-31 | RAPP May avg: -4.27% median: -4.27% win: 50% σ: 33.23% n: 2 2024-06-10 → 2026-07-31 | RAPP Jun avg: 18.27% median: 11.83% win: 100% σ: 16.94% n: 3 2024-06-10 → 2026-07-31 | RAPP Jul avg: 7.44% median: -1.66% win: 33% σ: 16.33% n: 3 2024-06-10 → 2026-07-31 | RAPP Aug avg: 9.25% median: 9.25% win: 50% σ: 19.12% n: 2 2024-06-10 → 2026-07-31 (current) | RAPP Sep avg: 31.31% median: 31.31% win: 50% σ: 52.54% n: 2 2024-06-10 → 2026-07-31 | RAPP Oct avg: 8.59% median: 8.59% win: 50% σ: 15.82% n: 2 2024-06-10 → 2026-07-31 | RAPP Nov avg: -2.10% median: -2.10% win: 50% σ: 6.78% n: 2 2024-06-10 → 2026-07-31 | RAPP Dec avg: -10.10% median: -10.10% win: 50% σ: 17.29% n: 2 2024-06-10 → 2026-07-31 |